Daina Graybosch
Stock Analyst at Leerink Partners
(0)
# 4626
Out of 5,319 analysts
132
Total ratings
25.00%
Success rate
-21.57%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TSVT 2seventy bio | Downgrades: Market Perform | 9 5 | 4.99 | 0.2% | 6 | Mar 11, 2025 | |
MRK Merck & Co | Maintains: Outperform | 136 119 | 77.92 | 52.72% | 19 | Jan 13, 2025 | |
LVTX LAVA Therapeutics | Downgrades: Market Perform | 11 2 | 1.34 | 49.25% | 6 | Dec 12, 2024 | |
BOLT Bolt Biotherapeutics | Downgrades: Market Perform | 3 1 | 0.35 | 185.71% | 8 | May 15, 2024 | |
ACLX Arcellx | Maintains: Outperform | 35 39 | 62.01 | -37.11% | 5 | Mar 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 5 3 | 0.64 | 368.75% | 10 | Feb 24, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 14 | 0.54 | 2492.59% | 4 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 62 10 | 1.11 | 800.9% | 7 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 100 60 | 0.73 | 8119.18% | 7 | Dec 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 10 9 | 1.94 | 363.92% | 10 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 38 | 7.88 | 382.23% | 2 | Nov 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 30 8 | 3.97 | 101.51% | 4 | Aug 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 223 224 | 98.88 | 126.54% | 16 | Jul 29, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | 1.8 | 1566.67% | 1 | Jul 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 21 7 | n/a | n/a | 4 | Jun 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 59 | 6.46 | 813.31% | 7 | May 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 17 | 0.91 | 1768.13% | 3 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 25 2 | n/a | n/a | 6 | Apr 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 9 | 1.49 | 504.03% | 4 | Feb 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 6 | n/a | n/a | 2 | Apr 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 68 | n/a | n/a | 1 | Dec 11, 2019 |